EGFR and oropharynx cancer: EGFRvIII, which is expressed in 25% of EGFR-expressing glioblastomas, or the E6 and E7 proteins of HPV, which are expressed in approximately 60% of oropharyngeal cancers and almost all cervical cancers, or MAGE are all targets for shared antigens [398,399].